340B Drug Pricing Program
See resources for hospitals on preserving hospital rights to appeal Medicare payments for 340B claims.
Plaintiffs’ notice of supplemental authority (ECF No. 78) asserts that HHS could reduce the Medicare appeals backlog by agreeing to toll the purported deadline for hospitals to file appeals related to the 340B Drug Discount Program pending the resolution of American Hospital Association v. Azar, No…
In a statement submitted for the hearing, AHA highlighted how hospitals are using savings from the 340B program to provide access to critical services to their communities.
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions Re: Perspectives on the 340B Drug Pricing Program
Tax-exempt hospitals in the 340B drug savings program provided $51.7 billion in total benefits to their communities in 2015, the most recent year for which data is available.
WASHINGTON, DC (March 1, 2018) – Hospitals of all kinds provide a full range of benefits to their communities. In a new analysis released today, the American Hospital Associati
In 2015 alone, the most recent year for which data is available, those tax-exempt hospitals participating in the 340B drug savings program provided $51.7B in total benefits to their communities.